Laboratory of Pathologic Anatomy

Sousse, Tunisia

Laboratory of Pathologic Anatomy

Sousse, Tunisia
SEARCH FILTERS
Time filter
Source Type

Tlili M.,Laboratory of Integrated Physiology | Rouatbi S.,Laboratory of Physiology and Functional Exploration | Gandia F.,Laboratory of Physiology and Functional Exploration | Hallegue D.,Laboratory of Integrated Physiology | And 8 more authors.
Brazilian Journal of Pharmaceutical Sciences | Year: 2015

The aim of this study was to investigate both functionally and structurally bronchodilator effects of Pituitary adenylate cyclase activating peptide (PACAP38) and acetyl-[Ala15, Ala20] PACAP38-polyamide, a potent PACAP38 analog, in rats challenged by methacholine (MeCh). Male Wistar rats were divided randomly into five groups. Groups 1 and 2 inhaled respectively aerosols of saline or increasing doses of MeCh (0.5, 1, 2.12, 4.25, 8.5, 17, 34 and 68mg/L). The other groups received terbutaline (Terb) (250 μg/rat) (10-6 M), PACAP38 (50 μg/rat) (0.1 mM) or PACAP38 analog (50 μg/rat) associated to MeCh from the dose of 4.25 mg/L. Total lung resistances (RL) were recorded before and 2 min after MeCh administration by pneumomultitest equipment. MeCh administration induced a significant and a dosedependent increase (p<0.05) of RL compared to control rats. Terb, PACAP38 and PACAP38 analog reversed significantly the MeCh-induced bronchial constriction, smooth muscle (SM) layer thickness and bronchial lumen mucus abundance. PACAP38 analog prevents effectively bronchial smooth muscle layer thickness, mucus hypersecretion and lumen decrease. Therefore, it may constitute a potent therapeutic bronchodilator. © 2015, Faculdade de Ciencias Farmaceuticas (Biblioteca). All rights reserved.


Tlili M.,University of Carthage | Tlili M.,French Institute of Health and Medical Research | Tlili M.,Institut Universitaire de France | Tlili M.,University of Rouen | And 11 more authors.
Oxidative Medicine and Cellular Longevity | Year: 2015

The rate of atmospheric vanadium is constantly increasing due to fossil fuel combustion. This environmental pollution favours vanadium exposure in particular to its vanadate form, causing occupational bronchial asthma and bronchitis. Based on the well admitted bronchodilator properties of the pituitary adenylate cyclase-activating polypeptide (PACAP), we investigated the ability of this neuropeptide to reverse the vanadate-induced airway hyperresponsiveness in rats. Exposure to ammonium metavanadate aerosols (5 mg/m3/h) for 15 minutes induced 4 hours later an array of pathophysiological events, including increase of bronchial resistance and histological alterations, activation of proinflammatory alveolar macrophages, and increased oxidative stress status. Powerfully, PACAP inhalation (0.1 mM) for 10 minutes alleviated many of these deleterious effects as demonstrated by a decrease of bronchial resistance and histological restoration. PACAP reduced the level of expression of mRNA encoding inflammatory chemokines (MIP-1α, MIP-2, and KC) and cytokines (IL-1α and TNF-α) in alveolar macrophages and improved the antioxidant status. PACAP reverses the vanadate-induced airway hyperresponsiveness not only through its bronchodilator activity but also by counteracting the proinflammatory and prooxidative effects of the metal. Then, the development of stable analogs of PACAP could represent a promising therapeutic alternative for the treatment of inflammatory respiratory disorders. © 2015 Mounira Tlili et al.

Loading Laboratory of Pathologic Anatomy collaborators
Loading Laboratory of Pathologic Anatomy collaborators